KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,613,467 | +48.3% | 582,905 | +38.6% | 0.00% | +100.0% |
| Q2 2023 | $3,784,862 | +103.8% | 420,536 | +78.0% | 0.00% | 0.0% |
| Q1 2023 | $1,856,898 | +104044.6% | 236,267 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,783 | -100.0% | 263,867 | -21.5% | 0.00% | -50.0% |
| Q3 2022 | $4,876,000 | +87.3% | 336,118 | +27.1% | 0.00% | +100.0% |
| Q2 2022 | $2,603,000 | +133.7% | 264,478 | +250.1% | 0.00% | – |
| Q1 2022 | $1,114,000 | -50.0% | 75,552 | -55.1% | 0.00% | -100.0% |
| Q4 2021 | $2,227,000 | -25.0% | 168,331 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $2,970,000 | -27.2% | 170,208 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,078,000 | -30.6% | 170,208 | -25.6% | 0.00% | -50.0% |
| Q1 2021 | $5,873,000 | +49.7% | 228,625 | +10.7% | 0.00% | +100.0% |
| Q4 2020 | $3,922,000 | +58.8% | 206,517 | +5.3% | 0.00% | 0.0% |
| Q3 2020 | $2,470,000 | +5.1% | 196,181 | +1.0% | 0.00% | 0.0% |
| Q2 2020 | $2,350,000 | +81.9% | 194,181 | +15.0% | 0.00% | 0.0% |
| Q1 2020 | $1,292,000 | -39.9% | 168,842 | +39.8% | 0.00% | 0.0% |
| Q4 2019 | $2,151,000 | +44.3% | 120,808 | -6.0% | 0.00% | 0.0% |
| Q3 2019 | $1,491,000 | -39.7% | 128,490 | +15.1% | 0.00% | 0.0% |
| Q2 2019 | $2,473,000 | +19.1% | 111,630 | +53.9% | 0.00% | 0.0% |
| Q1 2019 | $2,076,000 | +843.6% | 72,547 | +551.6% | 0.00% | – |
| Q4 2018 | $220,000 | -19.7% | 11,133 | -10.1% | 0.00% | – |
| Q3 2018 | $274,000 | – | 12,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |